Rossari Biotech Ltd (ROSSARI) is currently trading at 422.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Rossari Biotech is an India-headquartered specialty chemicals manufacturer focused on home and personal care, textile chemicals, animal health and nutrition, pharma excipients and related B2B specialty formulations with manufacturing at Dahej and Silvassa and a growing international footprint through export channels and a Thailand blending facility. Q2 FY27 marked Rossari’s highest-ever quarterly revenue at Rs. 697.6 crore, a 19% year-on-year increase, and highest-ever quarterly EBITDA of Rs. 87 crore, with gross margin at 31.6% and EBITDA margin at 12.5%, reflecting improved product mix and export traction despite raw material and freight headwinds. Management is actively pursuing margin enhancement through product mix optimization, portfolio rationalization of lower-margin B2C lines, commercialization of 70+ new products, and operating leverage; they are prioritizing debt reduction and working capital improvement with net debt reduced and working capital days down to 86. International expansion is a clear focus: export mix rose to ~31% of revenues this quarter, the Thailand blending facility is being ramped, and Rossari has taken a decisive step by leasing land for a Saudi Arabia Greenfield plant to access feedstock ecosystems and regional demand centers. Innovation is being scaled via the Rossari Global Research & Innovation Centre at Navi Mumbai and targeted green chemistries such as biosurfactants, pharma excipients and sustainable textile solutions, positioning the company to move up the value chain while navigating volatile EO and freight markets.

Over the past 52 weeks, Rossari Biotech Ltd has traded between a low of ₹372.90 and a high of ₹650.15. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Rossari Biotech Ltd has a market capitalization of approximately 2,336.52. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Rossari Biotech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 2,336.52 Cr, Rossari Biotech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Rossari Biotech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Rossari Biotech Ltd is 15.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The company informed exchanges about the transcript of its Q2 and H1 FY27 earnings conference call held on October 19, 2026, and also referenced related call materials.

Total revenues were ₹2,095.2 crore (₹20,952 million) in FY25, up 13.6% from ₹1,844.7 crore (₹18,447 million) in FY24.

The board meeting was scheduled for January 17, 2026 at 12:30 PM IST to consider unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025.